Ibuprofen ameliorates fatigue- and depressive-like behavior in tumor-bearing mice

Life Sciences

Volumn 143, Issue , 2015, Pages 65-70

  Norden, Diana M ^a   Mccarthy, Donna O ^b   Bicer, Sabahattin ^a   Devine, Raymond D ^a   Reiser, Peter J ^a   Godbout, Jonathan P ^a   Wold, Loren E ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b MARQUETTE UNIVERSITY   (United States)

Author keywords

Cancer; Depression; Fatigue; Ibuprofen; Neuroinflammation

Indexed keywords

IBUPROFEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; FATIGUE; FORCED SWIM TEST; GASTROCNEMIUS MUSCLE; GENE EXPRESSION; GRIP STRENGTH; HIPPOCAMPUS; MOUSE; MUSCLE ATROPHY; MUSCLE MASS; NONHUMAN; QUALITY OF LIFE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SKELETAL MUSCLE; ANIMAL; BAGG ALBINO MOUSE; COLONIC NEOPLASMS; COMPLICATION; DBA MOUSE; DEPRESSION; DRUG EFFECTS; FEMALE; MUSCLE STRENGTH; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLONIC NEOPLASMS; DEPRESSION; FATIGUE; FEMALE; IBUPROFEN; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; MUSCLE STRENGTH;

EID: 84946224467     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2015.10.020     Document Type: Article

References (46)

1. J.E. Bower, and D.M. Lamkin Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications Brain Behav. Immun. 30 Suppl 2013 S48 S57
2. O. Husson, W.A. Nieuwlaat, W.A. Oranje, H.R. Haak, L.V. van de Poll-Franse, and F. Mols Fatigue among short- and long-term thyroid cancer survivors: results from the population-based PROFILES registry Thyroid 23 2013 1247 1255
3. O. Minton, S. Alexander, and P.C. Stone Identification of factors associated with cancer related fatigue syndrome in disease-free breast cancer patients after completing primary treatment Breast Cancer Res. Treat. 136 2012 513 520
4. A.M. Berger, A.P. Abernethy, A. Atkinson, A.M. Barsevick, W.S. Breitbart, D. Cella, B. Cimprich, C. Cleeland, M.A. Eisenberger, C.P. Escalante, P.B. Jacobsen, P. Kaldor, J.A. Ligibel, B.A. Murphy, T. O'Connor, W.F. Pirl, E. Rodler, H.S. Rugo, J. Thomas, and L.I. Wagner Cancer-related fatigue Journal of the National Comprehensive Cancer Network: JNCCN 8 2010 904 931
5. J.E. Bower, P.A. Ganz, M.R. Irwin, L. Kwan, E.C. Breen, and S.W. Cole Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J. Clin. Oncol. 29 2011 3517 3522
6. H.J. Kim, A.M. Barsevick, C.Y. Fang, and C. Miaskowski Common biological pathways underlying the psychoneurological symptom cluster in cancer patients Cancer Nurs. 35 2012 E1 E20
7. M.M. Pertl, D. Hevey, N.T. Boyle, M.M. Hughes, S. Collier, A.M. O'Dwyer, A. Harkin, M.J. Kennedy, and T.J. Connor C-reactive protein predicts fatigue independently of depression in breast cancer patients prior to chemotherapy Brain Behav. Immun. 34 2013 108 119
8. X.S. Wang, L.A. Williams, S. Krishnan, Z. Liao, P. Liu, L. Mao, Q. Shi, G.M. Mobley, J.F. Woodruff, and C.S. Cleeland Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy Brain Behav. Immun. 26 2012 699 705
9. S. Acharyya, K.J. Ladner, L.L. Nelsen, J. Damrauer, P.J. Reiser, S. Swoap, and D.C. Guttridge Cancer cachexia is regulated by selective targeting of skeletal muscle gene products J. Clin. Invest. 114 2004 370 378
10. M. Sandri Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome Int. J. Biochem. Cell Biol. 45 2013 2121 2129
11. D.M. Norden, S. Bicer, Y. Clark, R. Jing, C.J. Henry, L.E. Wold, P.J. Reiser, J.P. Godbout, and D.O. McCarthy Tumor growth increases neuroinflammation, fatigue and depressive-like behavior prior to alterations in muscle function Brain Behav. Immun. 43 2015 76 85
12. W.A. He, E. Berardi, V.M. Cardillo, S. Acharyya, P. Aulino, J. Thomas-Ahner, J. Wang, M. Bloomston, P. Muscarella, P. Nau, N. Shah, M.E. Butchbach, K. Ladner, S. Adamo, M.A. Rudnicki, C. Keller, D. Coletti, F. Montanaro, and D.C. Guttridge NF-kappaB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia J. Clin. Invest. 123 2013 4821 4835
13. K.T. Murphy, A. Chee, J. Trieu, T. Naim, and G.S. Lynch Inhibition of the renin-angiotensin system improves physiological outcomes in mice with mild or severe cancer cachexia Int. J. Cancer 133 2013 1234 1246
14. V.E. Baracos, T. Reiman, M. Mourtzakis, I. Gioulbasanis, and S. Antoun Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis The American Journal of Clinical Nutrition 91 2010 1133S 1137S
15. E. Haroon, C.L. Raison, and A.H. Miller Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior Neuropsychopharmacology 37 2012 137 162
16. L.M. Pyter, V. Pineros, J.A. Galang, M.K. McClintock, and B.J. Prendergast Peripheral tumors induce depressive-like behaviors and cytokine production and alter hypothalamic-pituitary-adrenal axis regulation Proc. Natl. Acad. Sci. U. S. A. 106 2009 9069 9074
17. T.P. Braun, X. Zhu, M. Szumowski, G.D. Scott, A.J. Grossberg, P.R. Levasseur, K. Graham, S. Khan, S. Damaraju, W.F. Colmers, V.E. Baracos, and D.L. Marks Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis The Journal of Experimental Medicine 208 2011 2449 2463
18. M.D. Carmichael, J.M. Davis, E.A. Murphy, A.S. Brown, J.A. Carson, E.P. Mayer, and A. Ghaffar Role of brain IL-1beta on fatigue after exercise-induced muscle damage Am. J. Physiol. Regul. Integr. Comp. Physiol. 291 2006 R1344 R1348
19. D.M. Norden, R. Devine, S. Bicer, R. Jing, P.J. Reiser, L.E. Wold, J.P. Godbout, and D.O. McCarthy Fluoxetine prevents the development of depressive-like behavior in a mouse model of cancer related fatigue Physiol. Behav. 140 2015 230 235
20. M. Hamza, and R.A. Dionne Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition Curr. Mol. Pharmacol. 2 2009 1 14
21. L.A. Saleh, M. Hamza, N.H. El Gayar, A.A. Abd El-Samad, E.A. Nasr, and S.I. Masoud Ibuprofen suppresses depressive like behavior induced by BCG inoculation in mice: role of nitric oxide and prostaglandin Pharmacol. Biochem. Behav. 125 2014 29 39
22. R.L. Iyengar, S. Gandhi, A. Aneja, K. Thorpe, L. Razzouk, J. Greenberg, S. Mosovich, and M.E. Farkouh NSAIDs are associated with lower depression scores in patients with osteoarthritis The American Journal of Medicine 126 1017 2013 e1011 e1018
23. D.O. McCarthy, P. Whitney, A. Hitt, and S. Al-Majid Indomethacin and ibuprofen preserve gastrocnemius muscle mass in mice bearing the colon-26 adenocarcinoma Res. Nurs. Health 27 2004 174 184
24. A. Hitt, E. Graves, and D.O. McCarthy Indomethacin preserves muscle mass and reduces levels of E3 ligases and TNF receptor type 1 in the gastrocnemius muscle of tumor-bearing mice Res. Nurs. Health 28 2005 56 66
25. E. Graves, E. Ramsay, and D.O. McCarthy Inhibitors of COX activity preserve muscle mass in mice bearing the Lewis lung carcinoma, but not the B16 melanoma Res. Nurs. Health 29 2006 87 97
26. G. Mantovani, A. Maccio, C. Madeddu, R. Serpe, G. Antoni, E. Massa, M. Dessi, and F. Panzone Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia J Mol Med (Berl) 88 2010 85 92
27. H. Xu, D. Crawford, K.R. Hutchinson, D.J. Youtz, P.A. Lucchesi, M. Velten, D.O. McCarthy, and L.E. Wold Myocardial dysfunction in an animal model of cancer cachexia Life Sci. 88 2011 406 410
28. Y.Y. Clark, L.E. Wold, L.A. Szalacha, and D.O. McCarthy Ubiquinol reduces muscle wasting but not fatigue in tumor-bearing mice Biological Research for Nursing 17 2015 321 329
29. P.F. Cosper, and L.A. Leinwand Cancer causes cardiac atrophy and autophagy in a sexually dimorphic manner Cancer Res. 71 2011 1710 1720
30. M. Yang, J. Kim, J.-S. Kim, S.-H. Kim, J.-C. Kim, M.-J. Kang, U. Jung, T. Shin, H. Wang, and C. Moon Hippocampal dysfunctions in tumor-bearing mice Brain Behav. Immun. 36 2014 147 155
31. D.M. Norden, R. Devine, D.O. McCarthy, and L.E. Wold Storage conditions and passages alter IL-6 secretion in C26 adenocarcinoma cell lines MethodsX 2 2015 53 58
32. T. Okayama, S. Kokura, T. Ishikawa, S. Adachi, T. Hattori, T. Takagi, O. Handa, Y. Naito, and T. Yoshikawa Antitumor effect of pretreatment for colon cancer cells with hyperthermia plus geranylgeranylacetone in experimental metastasis models and a subcutaneous tumor model of colon cancer in mice Int. J. Hyperth. 25 2009 141 149
33. J.A. Zombeck, E.G. Fey, G.D. Lyng, and S.T. Sonis A clinically translatable mouse model for chemotherapy-related fatigue Comparative medicine 63 2013 491 497
34. K.T. Murphy, A. Chee, J. Trieu, T. Naim, and G.S. Lynch Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia Disease Models & Mechanisms 5 2012 533 545
35. J.P. Godbout, M. Moreau, J. Lestage, J. Chen, N.L. Sparkman, J.,. O. C., N. Castanon, K.W. Kelley, R. Dantzer, and R.W. Johnson Aging exacerbates depressive-like behavior in mice in response to activation of the peripheral innate immune system Neuropsychopharmacology 33 2008 2341 2351
36. P. Aulino, E. Berardi, V.M. Cardillo, E. Rizzuto, B. Perniconi, C. Ramina, F. Padula, E.P. Spugnini, A. Baldi, F. Faiola, S. Adamo, and D. Coletti Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse BMC Cancer 10 2010 363
37. P. Stone, A. Richardson, E. Ream, A.G. Smith, D.J. Kerr, and N. Kearney Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum Ann. Oncol. 11 2000 971 975
38. M. Hofman, J.L. Ryan, C.D. Figueroa-Moseley, P. Jean-Pierre, and G.R. Morrow Cancer-related fatigue: the scale of the problem Oncologist 12 Suppl 1 2007 4 10
39. P.A. Vissers, M.S. Thong, F. Pouwer, M.M. Zanders, J.W. Coebergh, and L.V. van de Poll-Franse The impact of comorbidity on health-related quality of life among cancer survivors: analyses of data from the PROFILES registry Journal of Cancer Survivorship: Research and Practice 7 2013 602 613
40. F. Mols, O. Husson, J.A. Roukema, and L.V. van de Poll-Franse Depressive symptoms are a risk factor for all-cause mortality: results from a prospective population-based study among 3,080 cancer survivors from the PROFILES registry Journal of Cancer Survivorship: Research and Practice 7 2013 484 492
41. T. Femenia, M. Gomez-Galan, M. Lindskog, and S. Magara Dysfunctional hippocampal activity affects emotion and cognition in mood disorders Brain Res. 1476 2012 58 70
42. A. Bonetto, T. Aydogdu, N. Kunzevitzky, D.C. Guttridge, S. Khuri, L.G. Koniaris, and T.A. Zimmers STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia PLoS One 6 2011 e22538
43. H. Kim, L. Chen, G. Lim, B. Sung, S. Wang, M.F. McCabe, G. Rusanescu, L. Yang, Y. Tian, and J. Mao Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression J. Clin. Invest. 122 2012 2940 2954
44. J. Haase, and E. Brown Integrating the monoamine, neurotrophin and cytokine hypotheses of depression - a central role for the serotonin transporter? Pharmacol. Ther. 147 2015 1 11
45. N. Hopwood, T. Maswanganyi, and L.M. Harden Comparison of anorexia, lethargy, and fever induced by bacterial and viral mimetics in rats Can. J. Physiol. Pharmacol. 87 2009 211 220
46. K. Lundholm, J. Gelin, A. Hyltander, C. Lonnroth, R. Sandstrom, G. Svaninger, U. Korner, M. Gulich, I. Karrefors, B. Norli, and et al. Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors Cancer Res. 54 1994 5602 5606